Hudson Bay Capital Management LP Ventyx Biosciences, Inc. Transaction History

Hudson Bay Capital Management LP

  • $21.9 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$29.8 - $40.3 $4.56 Million - $6.17 Million
153,000 Added 160.18%
248,515 $8.63 Million
Q2 2023

Aug 14, 2023
BUY
$28.53 - $39.55 $813,532 - $1.13 Million
28,515 Added 42.56%
95,515 $3.13 Million
Q1 2023

May 15, 2023
BUY
$29.51 - $46.65 $1.98 Million - $3.13 Million
67,000 New
67,000 $2.24 Million

Others Institutions Holding VTYX

# of Institutions
127
Shares Held
52.9M
Call Options Held
35.3K
Put Options Held
83K
View Full List

About Ventyx Biosciences, Inc.

VTYX Quotes by TradingView
  • Ticker VTYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,527,200
  • Market Cap $110M
  • Description
  • Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...
More about VTYX
Track This Portfolio

Track Hudson Bay Capital Management LP Portfolio

Follow Hudson Bay Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email